Montgomery & Co., LLC Initiates Coverage On Genentech, Inc.

SAN FRANCISCO--(BUSINESS WIRE)--Nov. 23, 2005--Montgomery & Co., LLC, a leading investment bank for growth companies in the information technology, communications, healthcare and media sectors, announced today that Research Analyst Shiv Kapoor has initiated coverage on Genentech Inc. (DNA - $98.28). Genentech is a biotech company focused on cancer therapies. Product sales in 2004 were driven primarily by Avastin, Rituxan and Herceptin, all of which are oncology therapies.